Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12694: Variant p.Ala220Val

2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial
Gene: BCKDHA
Feedback?
Variant information Variant position: help 220 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Alanine (A) to Valine (V) at position 220 (A220V, p.Ala220Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In MSUD1A. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 220 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 445 The length of the canonical sequence.
Location on the sequence: help RHFVTISSPLATQIPQAVGA A YAAKRANANRVVICYFGEGA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         RHFVTISSPLATQIPQAVGAAYAAKRA-NANRVVICYFGEGA

Chimpanzee                    RHFVTISSPLATQIPQAVGAAYAAKRA-NANRVVICYFGEG

Mouse                         RHFVTISSPLATQIPQAVGAAYAAKRA-NANRIVICYFGEG

Bovine                        RHFVTISSPLATQIPQAVGAAYAAKRA-NANRVVICYFGEG

Caenorhabditis elegans        RNFVTISSPLTTQLPQAVGSAYAFKQQKDNNRIAVVYFGDG

Slime mold                    INLQTISSPLTTQLPQAVGSSYAQKLA-GEKNCTIVYFGEG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 46 – 445 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial
Binding site 206 – 206
Binding site 207 – 207
Binding site 208 – 208
Binding site 211 – 211
Binding site 212 – 212
Binding site 238 – 238
Binding site 239 – 239
Binding site 240 – 240
Helix 212 – 226



Literature citations
Three Korean patients with maple syrup urine disease: four novel mutations in the BCKDHA gene.
Park H.D.; Lee D.H.; Hong Y.H.; Kang D.H.; Lee Y.K.; Song J.; Lee S.Y.; Kim J.W.; Ki C.S.; Lee Y.W.;
Ann. Clin. Lab. Sci. 41:167-173(2011)
Cited for: VARIANTS MSUD1A MET-211; VAL-220; CYS-346; LYS-PRO-403 INS AND 427-LEU-ALA-428 DELINS PRO;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.